Reaction Details |
| Report a problem with these data |
Target | C-X-C chemokine receptor type 3 |
---|
Ligand | BDBM50229377 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_461809 (CHEMBL928938) |
---|
IC50 | 17±n/a nM |
---|
Citation | Li, AR; Johnson, MG; Liu, J; Chen, X; Du, X; Mihalic, JT; Deignan, J; Gustin, DJ; Duquette, J; Fu, Z; Zhu, L; Marcus, AP; Bergeron, P; McGee, LR; Danao, J; Lemon, B; Carabeo, T; Sullivan, T; Ma, J; Tang, L; Tonn, G; Collins, TL; Medina, JC Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists. Bioorg Med Chem Lett18:688-93 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
C-X-C chemokine receptor type 3 |
---|
Name: | C-X-C chemokine receptor type 3 |
Synonyms: | AAO92295.1 | C-X-C chemokine receptor type 3 | C-X-C chemokine receptor type 3 (CXCR3) | C-X-C chemokine receptor type 3 (CXCR3A) | CXCR3 | CXCR3A | CXCR3_HUMAN | GPR9 | chemokine (C-X-C motif) receptor 3 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 40665.65 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 368 |
Sequence: | MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALY
SLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFG
SGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCL
LFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILA
VLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAK
SVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSET
SEASYSGL
|
|
|
BDBM50229377 |
---|
n/a |
---|
Name | BDBM50229377 |
Synonyms: | (R)-N-(1-(3-(4-cyanophenyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)acetamide | CHEMBL399285 |
Type | Small organic molecule |
Emp. Form. | C30H26F4N4O4S |
Mol. Mass. | 614.61 |
SMILES | CCS(=O)(=O)CCN([C@H](C)c1nc2ccccn2c(=O)c1-c1ccc(cc1)C#N)C(=O)Cc1ccc(F)c(c1)C(F)(F)F |
Structure |
|